← Axsome Therapeutics, Inc.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and Cash Equivalents, at Carrying Value | — | — | — | — | $183.9m | $86.5m | $200.8m | $386.2m | $315.4m | $322.9m | |
| Prepaid Expense and Other Assets, Current | $1.4m | $1.3m | $1.2m | $413k | $148k | $45k | $2.8m | $8.1m | $12.0m | $13.7m | |
| Inventory, Net | — | — | — | — | — | — | $4.3m | $15.1m | $15.7m | $27.9m | |
| Assets, Current | $38.0m | $35.3m | $15.2m | $220.4m | $184.0m | $86.5m | $245.6m | $504.3m | $485.1m | $589.0m | |
| Property, Plant and Equipment, Net | $101k | $68k | $52k | $31k | $53k | $284k | $723k | $846k | $584k | $562k | |
| Goodwill | — | — | — | — | — | — | $10.3m | $12.0m | $12.0m | $12.0m | |
| Intangible Assets, Net (Excluding Goodwill) | — | — | — | — | — | — | $59.7m | $53.3m | $46.9m | $40.5m | |
| Operating Lease, Right-of-Use Asset | — | — | — | — | $1.7m | $660k | $420k | $6.8m | $5.4m | $20.9m | |
| Other Assets, Noncurrent | $113k | $188k | $112k | $140k | $317k | $323k | — | — | — | — | |
| Additional Financial Items | |||||||||||
| Accounts Receivable, after Allowance for Credit Loss, Current | — | — | — | — | — | — | $37.7m | $94.8m | $142.0m | $224.5m | |
| Assets | $38.2m | $35.6m | $15.4m | $220.5m | $186.1m | $87.8m | $331.5m | $588.2m | $568.5m | $689.8m | |
| LIABILITIES AND EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Operating Lease, Liability, Current | — | — | — | — | $1.2m | $621k | $425k | $1.3m | $1.8m | $434k | |
| Accounts Payable, Current | $4.1m | $3.4m | $3.7m | $10.9m | $13.5m | $13.1m | $38.6m | $40.7m | $72.0m | $65.5m | |
| Operating Lease, Liability, Noncurrent | — | — | — | — | $582k | $621k | $425k | $7.0m | $6.0m | $23.2m | |
| Long-term Debt, Current Maturities | $269k | $3.3m | $3.3m | $2.6m | — | — | — | — | — | $70.0m | |
| Long-term Debt, Excluding Current Maturities | $9.5m | $6.7m | $3.6m | $17.3m | $48.3m | $49.1m | $94.3m | $178.1m | $180.7m | $117.7m | |
| Liabilities, Current | $7.2m | $12.2m | $10.8m | $24.5m | $23.4m | $23.1m | $96.6m | $138.9m | $230.1m | $378.8m | |
| Liabilities | $16.6m | $18.8m | $14.4m | $41.8m | $72.3m | $72.2m | $221.9m | $397.3m | $511.5m | $601.5m | |
| Stockholders’ equity: | |||||||||||
| Common Stock, Value, Issued | $2k | $3k | $3k | $4k | $4k | $4k | $4k | $5k | $5k | $5k | |
| Additional Paid in Capital | $69.2m | $93.3m | $108.5m | $354.6m | $392.6m | $424.8m | $705.9m | $1.0b | $1.2b | $1.4b | |
| Retained Earnings (Accumulated Deficit) | ($47.6m) | ($76.6m) | ($107.6m) | ($175.9m) | ($278.8m) | ($409.2m) | ($596.3m) | ($835.6m) | ($1.1b) | ($1.3b) | |
| Stockholders' Equity Attributable to Parent | $21.6m | $16.7m | $938k | $178.7m | $113.8m | $15.6m | $109.6m | $191.0m | $57.0m | $88.3m | |
| Liabilities and Equity | $38.2m | $35.6m | $15.4m | $220.5m | $186.1m | $87.8m | $331.5m | $588.2m | $568.5m | $689.8m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.